Platinum-induced ototoxicity
MONDO:0800178Progressive, bilateral, and irreversible sensorineural hearing loss as a frequently encountered side effect of platinum-based chemotherapy such as cisplatin and carboplatin.
Also known as: deafness, platinum-induced, platinum-related ototoxicity
7 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New brain wave test could revolutionize hearing loss diagnosis
Diagnosis CompletedThis study tested a new device called CochSyn that measures brain waves to detect hearing damage. Researchers compared results from 65 adults with and without hearing difficulties. The goal was to see if the device can accurately identify different types of hearing loss and be ea…
Phase: NA • Sponsor: University Ghent • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Can a pill shield ears from chemo damage?
Prevention CompletedThis study tests whether the drug SENS-401 can prevent hearing loss caused by cisplatin, a common chemotherapy. Adults with cancer who are scheduled to receive cisplatin take SENS-401 before, during, and after treatment. Hearing is measured with a standard test to see if the drug…
Phase: PHASE2 • Sponsor: Sensorion • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC